Vanguard Investments Australia
KMTS

Vanguard Investments Australia’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Investments Australia’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Hold
6,481
– – ﹤0.01% 2188
2026
Q1 		$129K Buy
+6,481
New +$153K ﹤0.01% 2216

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Investments Australia's KMTS Position: Q2 2026 in Review

Vanguard Investments Australia held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 6,481 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Vanguard Investments Australia first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Vanguard Investments Australia held 6,481 shares of Kestra Medical Technologies worth $165K as of Q2 2026.
  • Vanguard Investments Australia left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2188 holding.
  • Vanguard Investments Australia first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.